^SYDNEY, Australia, May 09, 2023 (GLOBE NEWSWIRE) — Novotech, the leading, on
Asia-Pacific oriented contract research institute for the
Field of biotechnology, in collaboration with Citeline, conducted a survey
conducted among global biotechnology professionals who are engaged with the current
and future prospects for the clinical pipeline, the largest
Challenges in clinical trials and the shift in perspective related to
places of study dealt with.
A key finding of the report is that costs account for 32% of respondents
are the top concern, followed by patient recruitment at 29%
Download the report here
(https://pages.pharmaintelligence.informa.com/novotech-bio-research-report)
The report provides insights into the trends and issues in clinical trials in
of biotechnology, now that companies are trying to get funding for
to ensure further and future development.
The most important subject areas include:
* Modalities: current pipeline versus future investments
* Top operational challenges in clinical trials
* The role of APAC: China and Australia offer key advantages
* Success factors for clinical trials and strategies from
contract research institutes
The report also looks at trends and the perceptions of
Industry experts in various therapeutic areas.
The report states, for example:?When asked about the
most promising form of therapy for future investments and developments
CGTs came first (26%), followed by mRNA (22%) and
Antibody therapeutics (19%).”
Novotech offers biotechnology companies a unique and
unparalleled range of contract research services for the early
to late stage in the US and Europe, with emphasis on the
Asia-Pacific region is where the company has a good reputation
conducting high-quality accelerated clinical trials.
Novotech, recognized as one of the top 10 world leaders
Awarded the Asia Pacific Cell & Gene
Therapy Clinical Trials Excellence Award and the Asia-Pacific Contract
Research Organization Company of the Year Award and has won the last three
signed 45 lead trial site partnership agreements over the past 45 years.
About Novotech Novotech-CRO.com (https://novotech-cro.com/)
Novotech is the leading contract research organization in Asia Pacific
Space with worldwide implementation possibilities. Novotech is a clinical
CRO with laboratories, phase I facilities, consulting services
for drug development and FDA approvals expertise
Experience with over 5,000 clinical projects, including clinical trials
of phases I to IV and bioequivalence studies. Novotech is able to customers
from the biotechnology industry in conducting clinical studies in the
Asia Pacific, US and Europe. Novotech
has over 3,000 employees worldwide and 34 offices in the US, Europe
and in the Asia-Pacific region.
Visit https://novotech-cro.com/contact for more information
°